- Report
- March 2024
- 191 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- March 2024
- 186 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- January 2024
- 200 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- November 2023
- 175 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- November 2023
- 150 Pages
Global
From €4681EUR$4,850USD£4,016GBP
- Report
- July 2023
- 115 Pages
Global
From €3716EUR$3,850USD£3,188GBP
- Report
- April 2024
- 898 Pages
Global
From €5405EUR$5,600USD£4,637GBP
- Report
- April 2024
- 93 Pages
Global
From €5405EUR$5,600USD£4,637GBP
- Report
- January 2024
- 285 Pages
Global
From €9169EUR$9,500USD£7,866GBP
- Report
- February 2024
- 115 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- March 2024
- 30 Pages
Global
From €2654EUR$2,750USD£2,277GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1930EUR$2,000USD£1,656GBP
- Drug Pipelines
- April 2024
- 230 Pages
Global
From €2896EUR$3,000USD£2,484GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1930EUR$2,000USD£1,656GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1448EUR$1,500USD£1,242GBP
- Clinical Trials
- April 2024
- 75 Pages
Global
From €1448EUR$1,500USD£1,242GBP
- Report
- March 2024
- 30 Pages
Global
From €2654EUR$2,750USD£2,277GBP
- Report
- March 2024
- 30 Pages
Global
From €2654EUR$2,750USD£2,277GBP
- Report
- March 2024
- 30 Pages
Global
From €2654EUR$2,750USD£2,277GBP
- Report
- March 2024
- 30 Pages
Global
From €3137EUR$3,250USD£2,691GBP
Levodopa is a drug used to treat Parkinson's disease, a neurological disorder that affects movement. It is a dopamine precursor, meaning it is converted into dopamine in the brain, which helps to reduce the symptoms of Parkinson's. Levodopa is usually taken in combination with other drugs, such as carbidopa, to increase its effectiveness. It is one of the most commonly prescribed drugs for Parkinson's, and is often the first line of treatment.
Levodopa is a part of the larger Central Nervous System (CNS) drug market, which includes drugs used to treat a variety of neurological disorders. The CNS drug market is highly competitive, with many different companies offering various treatments.
Some of the companies in the Levodopa market include Merck, Novartis, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more